Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Eur J Neurol. 2019 Aug;26(8):1082-1090. doi: 10.1111/ene.13943. Epub 2019 Mar 15.
Oxidative stress plays an important role in acute ischaemic stroke. However, the association of oxidative lipoprotein markers, including oxidized low-density lipoprotein (oxLDL), oxLDL:high-density lipoprotein (HDL) and oxLDL:low-density lipoprotein (LDL), with functional outcome of minor stroke or transient ischaemic attack (TIA) remains unclear. We aimed to investigate the association between oxidative lipoprotein markers and poor functional outcome in patients with minor stroke or TIA.
All patients with minor stroke or TIA were recruited from the Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) trial. The poor functional outcome included modified Rankin Scale (mRS) score 2-6 and 3-6 at 90-day and 12-month follow-up. Multivariate logistic regression was used to investigate the associations of oxLDL, oxLDL:HDL and oxLDL:LDL with poor functional outcome.
Among 3019 patients included in this study, the median (interquartile range) oxLDL, oxLDL:HDL and oxLDL:LDL were 13.96 (6.65-28.81), 4.52 (2.08-9.32) and 11.73 (5.27-24.85) μg/dL, respectively. After adjusted for confounding factors, patients in the highest oxLDL quartile had a higher proportion of mRS score 2-6 at 90 days [hazard ratio (HR), 1.78; 95% confidence interval (CI), 1.26-2.52] and 12 months (HR, 1.42; 95% CI, 1.01-1.99), and mRS score 3-6 at 90 days (HR, 1.98; 95% CI, 1.29-3.04) and 12 months (HR, 1.77; 95% CI, 1.09-2.89) when compared with the lowest oxLDL quartile (P < 0.05). Similar results were found for oxLDL:HDL and oxLDL:LDL.
Higher levels of oxidative lipoprotein markers are independent predictors of poor functional outcome in patients with minor stroke or TIA at 90 days and 12 months.
氧化应激在急性缺血性卒中中起重要作用。然而,氧化脂蛋白标志物(包括氧化低密度脂蛋白[oxLDL]、oxLDL:高密度脂蛋白[HDL]和 oxLDL:低密度脂蛋白[LDL])与小卒中或短暂性脑缺血发作(TIA)的功能结局之间的关联仍不清楚。我们旨在研究氧化脂蛋白标志物与小卒中或 TIA 患者不良功能结局之间的关系。
所有小卒中或 TIA 患者均来自氯吡格雷在高危急性非致残性脑血管事件(CHANCE)试验中招募。不良功能结局包括改良Rankin 量表(mRS)评分 2-6 和 90 天及 12 个月随访时的 3-6。采用多变量逻辑回归分析 oxLDL、oxLDL:HDL 和 oxLDL:LDL 与不良功能结局的关系。
在本研究纳入的 3019 例患者中,oxLDL、oxLDL:HDL 和 oxLDL:LDL 的中位数(四分位数间距)分别为 13.96(6.65-28.81)、4.52(2.08-9.32)和 11.73(5.27-24.85)μg/dL。调整混杂因素后,oxLDL 四分位最高组患者在 90 天时 mRS 评分 2-6 的比例较高[风险比(HR),1.78;95%置信区间(CI),1.26-2.52]和 12 个月(HR,1.42;95% CI,1.01-1.99),以及 mRS 评分 3-6 在 90 天(HR,1.98;95% CI,1.29-3.04)和 12 个月(HR,1.77;95% CI,1.09-2.89)与 oxLDL 四分位最低组相比(P<0.05)。oxLDL:HDL 和 oxLDL:LDL 也有类似结果。
较高水平的氧化脂蛋白标志物是小卒中或 TIA 患者 90 天和 12 个月时不良功能结局的独立预测因子。